×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ZVRA – zevra therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ZVRA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/17
07:47 am
zvra
Zevra Therapeutics to be Added to Nasdaq Biotechnology Index (Nasdaq: NBI) Effective December 23, 2024 [Yahoo! Finance]
Low
Report
Zevra Therapeutics to be Added to Nasdaq Biotechnology Index (Nasdaq: NBI) Effective December 23, 2024 [Yahoo! Finance]
12/17
07:30 am
zvra
Zevra Therapeutics to be Added to Nasdaq Biotechnology Index (Nasdaq: NBI) Effective December 23, 2024
Low
Report
Zevra Therapeutics to be Added to Nasdaq Biotechnology Index (Nasdaq: NBI) Effective December 23, 2024
12/6
05:00 pm
zvra
Zevra Therapeutics Announces Organizational Changes
Medium
Report
Zevra Therapeutics Announces Organizational Changes
11/26
07:30 am
zvra
Zevra Therapeutics to Participate at Upcoming Investor Conferences
Low
Report
Zevra Therapeutics to Participate at Upcoming Investor Conferences
11/21
04:51 pm
zvra
Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFA™ (arimoclomol) for Treatment of Niemann-Pick Disease Type C
Medium
Report
Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFA™ (arimoclomol) for Treatment of Niemann-Pick Disease Type C
11/20
08:06 am
zvra
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Low
Report
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
11/14
11:23 am
zvra
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $25.00 to $23.00. They now have a "buy" rating on the stock.
Medium
Report
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $25.00 to $23.00. They now have a "buy" rating on the stock.
11/13
02:26 am
zvra
Zevra Therapeutics Inc (ZVRA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst ... [Yahoo! Finance]
Medium
Report
Zevra Therapeutics Inc (ZVRA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst ... [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/6
05:28 pm
zvra
Form 8-K ZEVRA THERAPEUTICS, INC. For: Dec 02
Medium
Report
Form 8-K ZEVRA THERAPEUTICS, INC. For: Dec 02
11/22
06:02 am
zvra
Form 8-K ZEVRA THERAPEUTICS, INC. For: Nov 21
Medium
Report
Form 8-K ZEVRA THERAPEUTICS, INC. For: Nov 21
11/14
04:56 pm
zvra
Form SCHEDULE 13G/A ZEVRA THERAPEUTICS, INC. Filed by: Nantahala Capital Management, LLC
Medium
Report
Form SCHEDULE 13G/A ZEVRA THERAPEUTICS, INC. Filed by: Nantahala Capital Management, LLC
11/14
01:00 pm
zvra
Form SC 13G ZEVRA THERAPEUTICS, INC. Filed by: Woodline Partners LP
Low
Report
Form SC 13G ZEVRA THERAPEUTICS, INC. Filed by: Woodline Partners LP
11/13
04:19 pm
zvra
Form 10-Q ZEVRA THERAPEUTICS, INC. For: Sep 30
Medium
Report
Form 10-Q ZEVRA THERAPEUTICS, INC. For: Sep 30
11/12
05:59 pm
zvra
Form SC 13G/A ZEVRA THERAPEUTICS, INC. Filed by: VANGUARD GROUP INC
Medium
Report
Form SC 13G/A ZEVRA THERAPEUTICS, INC. Filed by: VANGUARD GROUP INC
11/12
04:24 pm
zvra
Form 8-K ZEVRA THERAPEUTICS, INC. For: Nov 12
Medium
Report
Form 8-K ZEVRA THERAPEUTICS, INC. For: Nov 12
11/4
02:15 pm
zvra
Form SC 13G/A ZEVRA THERAPEUTICS, INC. Filed by: VANGUARD GROUP INC
Low
Report
Form SC 13G/A ZEVRA THERAPEUTICS, INC. Filed by: VANGUARD GROUP INC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: